Palo Alto Networks Inc vs Revolution Medicines Inc. Common Stock — how do they compare? Palo Alto Networks Inc trades at $410.22 (market cap $331.76B), while Revolution Medicines Inc. Common Stock trades at $186.71 (market cap $40.32B). The key difference: Palo Alto Networks Inc is far larger — about 8.2× Revolution Medicines Inc. Common Stock's market cap, and Palo Alto Networks Inc is trading nearer its 52-week high, Revolution Medicines Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Palo Alto Networks Inc for 82 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| PANW | RVMD | |
|---|---|---|
Market Cap | $331.76B | $40.32B |
Volume | 3,886,927 | 4,855,734 |
Sector | Technology | Health |
52-Week High | $419.91 | $221.15 |
52-Week Low | $141.67 | $47.50 |
Typical Hold Time | 82 Days | 0 Days |
Enterprise Value | $331.19B | $37.02B |
Signals from Pluang's Aura AI — not financial advice
Palo Alto Networks (PANW) trades at $405.41, down 3.45% today but maintains a bullish technical outlook with strong moving average signals. The company demonstrates robust revenue growth, reaching $9.22B in 2025, though net margins compressed to 2.67%. Recent AI security initiatives, including Unit 42 AI defense service, position PANW for continued growth in the cybersecurity sector.
PANW presents a mixed investment case with strong AI-driven growth potential offset by premium valuations (P/E 1,013.93, P/S 26.99). Analyst consensus remains strongly bullish (72% buy ratings) with a $398.70 price target. Key risks include valuation sensitivity and competitive pressures in the rapidly evolving cybersecurity landscape.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →